Synthesis, spectroscopic, and anticancerous properties of mixed ligand palladium(II) and silver(I) complexes with 4,6-diamino-5-hydroxy-2- mercaptopyrimidine and 2,2′-bipyridyl

Metal-Based Drugs

Volumn 2008, Issue , 2008, Pages

  Mostafa, Sahar I ^a   Badria, Farid A ^b  

^a Mansoura University   (Egypt)

^b MANSOURA UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL; PALLADIUM (4,6 DIAMINO 5 2 MERCAPTOPYRIMIDINE); SILVER (4,6 DIAMINO 5 2 MERCAPTOPYRIMIDINE);

ALOPECIA; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG SYNTHESIS; EHRLICH ASCITES TUMOR CELL; FLU LIKE SYNDROME; HUMAN; HUMAN CELL; INFRARED RADIATION; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; THERMAL ANALYSIS;

EID: 43849083715     PISSN: 07930291     EISSN: None     Source Type: Journal    
DOI: 10.1155/2008/723634     Document Type: Article

References (42)

1. Hacker M. P., Douple E. B., Krakoff I. H., Platinium Coordination Complexes in Cancer Chemotherapy 1984 Dordrecht, The Netherlands Martinus Nijhoff
2. Coluccia M., Nassi A., Loseto F., A trans-platinum complex showing higher antitumor activity than the cis congeners Journal of Medicinal Chemistry 1993 36 4 510 512
3. Harmers F. P. T., Gispen W. H., Neijt J. P., Neurotoxic side-effects of cisplatin European Journal of Cancer 1991 27 372 376
4. Mostafa S. I., Mixed ligand complexes with 2-piperidine-carboxylic acid as primary ligand and ethylene diamine, 2, 2′ -bipyridyl, 1,10-phenanthroline and 2(2′ -pyridyl)quinoxaline as secondary ligands: preparation, characterization and biological activity Transition Metal Chemistry 2007 32 6 769 775
5. Mostafa S. I., Synthesis, characterization and antineoplastic activity of 5-chloro-2,3-dihydroxypyridine transition metal complexes. Journal of Coordination Chemistry, in press
6. Jin V. X., Ranford J. D., Complexes of platinum(II) or palladium(II) with 1,10-phenanthroline and amino acids Inorganica Chimica Acta 2000 304 1 38 44
7. Cavigiolio G., Benedetto L., Boccaleri E., Colangelo D., Viano H., Osella D., Pt(II) complexes with different N-donor aromatic ligands for specific inhibition of telomerase Inorganica Chimica Acta 2000 305 1 61 68
8. Hadjikakou S. K., Demertzis M. A., Kubicki M., Kovala-Demertzis D., Organotin adducts with pyrimidinethione: crystal structure of dimethyldi(pyrimidine-2-thiolato)tin(IV) and diphenyldi(pyrimidine-2-thiolato) tin(IV) Applied Organometallic Chemistry 2000 14 11 727 734
9. Krishnamurthy V. N., Naglowara Rao K. V., Narasimha Rao P. L., Praphulla B., Some potential antiviral agents British Journal of Pharmacology and Chemotherapy 1967 31 1 1 10
10. Couce M. D., Faraglia G., Russo U., 2-mercaptopyridine derivatives as neutral or ionic donors towards tin tetrahalides New Journal of Chemistry 1997 21 10 1103 1111
11. D'Ancona S., Magnolfi G., Guidetti G., Effects of 6, 6′ -dithiodinicotinic acid (CPDS) and its metabolite 6-mercaptonicotinic acid (6-MNA) on murine and hamster fibroblasts (3T3 and BHK) and murine metastatic melanoma cells (F10) Chemioterapia 1986 5 4 219 227
12. Mostafa S. I., Hadjiliadis N., New biologically active transition metal complexes of 2-mercapto-4,6-diamino-5-hydroxypyrimidine Inorganic Chemistry: An Indian Journal 2007 2 3 186 192
13. Griffith W. P., Mostafa S. I., Complexes of esculetin with second and third row transition elements Polyhedron 1992 11 8 871 877
14. Sheeji K. R., Kuttan G., Kuttan R., Amala Research Bulletin 1997 17 73 76
15. Geary W. J., Coordination Chemistry Reviews 1981 7 81
16. Abdullah A., Huq F., Chowdhury A., Tayyem H., Beale P., Fisher K., Studies on the synthesis, characterization, binding with DNA and activities of two cis -planaramineplatinum(II) complexes of the formml: cis-PtL(NH3)Cl2 where L = 3-hydroxypyridine and 2,3-diaminopyridine BMC Chemical Biology 2006 6, article 3 1472 1484
17. Popovic Z., Calogovic D. M., Hasic J., Topic D. V., Preparation and spectroscopic properties of the complexes of mercuric thiocyanate with pyridine-2-thione and pyridine-2-carboxylic acid. Crystal and molecular structure of two polymorphs of Hg(SCN)2(C5H5NS)2 Inorganica Chimica Acta 1999 285 2 208 216
18. Gutierrez M. D., Lopez R., Romero M. A., Salas J. M., Spectroscopic studies of some Pd(II), Pt(II), Ag(I), and Au(III) complexes of 4,6-diamino-2-thiopyrimidine and 4,6-diamino-2-methylthiopyrimidine. Structure and binding site determination Canadian Journal Chemistry 1988 66 2 249 255
19. 2O Polyhedron 2005 24 12 1435 1444
20. Glolub G., Cohen H., Paoletti P., Bencini A., Meyerstein D., Copper-(I) and -(II) complexes with tertiary linear polyamines of the type Me2NCH2(CH2NMeCH2)nCH2NMe2(n=1-4) Journal of the Chemical Society, Dalton Transactions 1996 10 2055 2060
21. Mostafa S. I., Abd El-Maksoud S. A., Synthesis and characterization of some transition metal complexes of 2-amino-3-hydroxypyridine and its application in corrosion inhibition Monatshefte für Chemie 1998 129 5 455 466
22. Guta M., Srivastava M. N., Synthesis and characterization of complexes of copper(II), nickel(II), cobalt(II) and zinc(II) with alanine and uracil or 2-thiouracil Synthesis and Reactivity in Inorganic, Metal-Organic, and Nano-Metal Chemistry 1996 26 2 305 320
23. Mostafa S. I., Kabil M. A., Saad E. M., El-Asmy A. A., Ligational and analytical applications of a uracil derivative toward some transition metal ions Journal of Coordination Chemistry 2006 59 3 279 293
24. Ma C.-L., Shi Y., Zhang Q.-F., Jiang Q., Syntheses, characterization and crystal structures of diorganotin compounds with 2-mercaptopyrimidine and 4-amino-2-mercaptopyrimidine Polyhedron 2005 24 10 1109 1116
25. Castro R., Vazquez J. A. G., Romero J., Sousa A., Pritchard R., McAuliffe C. A., 4,6-dimethylpyrimidine-2-thionato (dmpym t-) complexes of nickel(II) and cadmium(II). Crystal structure of [Cd(dmpymt)2]: a compound with a calixarene-like structure Journal of the Chemical Society, Dalton Transactions 1994 7 1115 1120
26. Haj M. A., Quiros M., Salas J. M., Faure R., Silver complexes with triazolopyrimidine ligands containing an exocyclic oxygen atomml: X-ray evidence for an unusual tautomeric form Journal of the Chemical Society, Dalton Transactions 2001 11 1798 1801
27. Mostafa S. I., Bekheit M. M., Synthesis and structure studies of complexes of some second row transition metals with 1-(phenylacetyl and phenoxyacetyl)-4-phenyl-3- thiosemicarbazide Chemical and Pharmaceutical Bulletin 2000 48 2 266 271
28. Sabin F., Ryu C. K., Fork P., Vogler A., Photophysical properties of hexanuclear copper(I) and silver(I) clusters Inorganic Chemistry 1992 31 10 1941 1946
29. Omary M. A., Webb T. R., Assefa Z., Shankle G. E., Patterson H. H., Crystal structure, electronic structure, and temperature-dependent Raman spectra of Tl [Ag(CN)2]: evidence for ligand-unsupported argentophilic interactions Inorganic Chemistry 1998 37 6 1380 1386
30. Calvo M., Lanfredi A. M., Oro L., Synthesis and properties of rhodium(I) chloranilate and 2,5-dihydroxy-1,4-benzoquinonate complexes. Crystal structures of the binuclear [ Rh2 (μ -CA) (cod)2 ] and tetranuclear [ Rh4 (μ-CA)2 (cod)4 ] complexes (CA = cbloranilate anion) Inorganic Chemistry 1993 32 7 1147 1152
31. Griffith W. P., Mostafa S. I., Complexes of 3-hydroxypyridin-2-one and 1,2-dimethyl-3-hydroxypyridin-4-one with second and third row elements of groups 6, 7 and 8 Polyhedron 1992 11 23 2997 3005
32. Aguado D., Montoya T., Ferrer J., Seco A., Relating ions concentration variations to conductivity variations in a sequencing batch reactor operated for enhanced biological phosphorus removal Environmental Modelling & Software 2006 21 6 845 851
33. Castellan G. W., Physical Chemistry 1983 Menlo Park, Calif, USA The Benjamin edited by L. Rogers
34. Clarkson B. D., Burchenal J. H., Preliminary screening of antineoplastic drugs Progress in Clinical Cancer 1965 1 625 629
35. Oberling C., Guerin M., The role of viruses in the production of cancer Advances in Cancer Research 1954 2 353 423
36. Ardalan B., Buscagila M. D., Schein P. S., Tumor 5-fluorodeoxyuridylate concentration as a determinant of 5-fluorouracil response Biochemical Pharmacology 1978 27 16 2009 2013
37. Yoshisue K., Hironaga Z., Yamaguchi S., Yamamoto A., Nagayama S., Kawaguchi Y., Reduction of 5-fluorouracil (5-FU) gastrointestinal (GI) toxicity resulting from the protection of thymidylate synthase (TS) in GI tissue by repeated simultaneous administration of potassium oxonate (Oxo) in rats Cancer Chemotherapy and Pharmacology 2000 46 1 51 56
38. Romerosa A., Bergamini P., Bertolasi V., Biologically active platinum complexes containing 8-thiotheophylline and 8-(methylthio)theophylline Inorganic Chemistry 2004 43 3 905 913
39. Lebwohl D., Canerra R., Clinical development of platinum complexes in cancer therapy: an historical perspective and an update European Journal of Cancer 1998 34 10 1522 1534
40. Osinsky S., 1998 December. Ukr Patent, Appl., no. 981 27 052
41. Osinsky S., Levitin I., Bubnovskaya L., Proceedings of the 6th Internet World Congress for Biomedical Sciences (INABIS '00) February 2000 Ciudad Real, Spain 1 6
42. Sur P., Ganguly D. K., Tea plant root extract (TRE) as an antineoplastic agent Planta Medica 1994 60 106 109